Home / Dabigatran Etexilate / Australia
AU ATC B01AE07 · updated 2 Nov 2026
Dabigatran Etexilate shortage in Australia
Is there a Dabigatran Etexilate shortage in Australia?
Yes. As of 2 Nov 2026, 5 Dabigatran Etexilate products are reported short in Australia, the first since 17 Aug 2026. The company estimate for the return is 20 Nov 2026 (latest 1 Feb 2027). Main reason: not stated.
Also short in Canada, Germany, Italy, Spain, Austria, Belgium, Czechia, Norway, Sweden. All countries.
Affected products in Australia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AU | PHARMACOR DABIGATRAN dabigatran etexilate (as mesilate) 110 mg capsule bottle pack | 17 Aug 2026 | 1 Feb 2027 | Not stated | |
| AU | DABIGATRAN VIATRIS dabigatran etexilate (as mesilate) 110 mg capsule blister pack | 7 Oct 2026 | 20 Nov 2026 | Not stated | |
| AU | DABIGATRAN VIATRIS dabigatran etexilate (as mesilate) 150 mg capsule blister pack | 7 Oct 2026 | 20 Nov 2026 | Not stated | |
| AU | PHARMACOR DABIGATRAN dabigatran etexilate (as mesilate) 110 mg capsule blister pack | 7 Oct 2026 | 1 Jan 2027 | Not stated | |
| AU | PHARMACOR DABIGATRAN dabigatran etexilate (as mesilate) 150 mg capsule blister pack | 23 Oct 2026 | 1 Feb 2027 | Not stated |
Source
Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.